Literature DB >> 24569393

Validation of a disease-specific health-related quality of life measure in adult Italian patients with systemic lupus erythematosus: LupusQoL-IT.

F Conti1, C Perricone2, G Reboldi3, M Gawlicki4, I Bartosiewicz2, V A Pacucci2, L Massaro2, F Miranda2, S Truglia2, C Alessandri2, F R Spinelli2, L-S Teh5, F Ceccarelli2, G Valesini2.   

Abstract

OBJECTIVE: The objective of this paper is to assess the validity of a linguistically validated version of the Lupus Quality of Life (LupusQoL(©)) in Italian patients affected by systemic lupus erythematosus (SLE).
METHODS: Consecutive SLE patients completed the Italian version of the LupusQoL(©) and the Short Form (SF)-36. Disease activity was evaluated by the SLE disease activity Index-2000 (SLEDAI-2 K), and chronic damage by the Systemic Lupus International Collaborating Clinics/American College Rheumatology (ACR) Damage Index score (SDI). Internal consistency and test-retest reliability, convergent and discriminant validity were examined. Factor analysis with varimax rotation was performed.
RESULTS: A total of 117 Italian SLE patients (M:F 13:104; mean age 40.6 ± 11.6 years, mean disease duration 127.5 ± 94.1 months) were recruited into the study. The Italian version of the LupusQoL(©) demonstrated substantial evidence of convergent validity in these patients when compared with equivalent items of the SF-36. In addition, the LupusQoL(©) discriminated between patients with different degrees of disease activity as measured by the SLEDAI-2 K. SLE patients with higher disease activity (SLEDAI-2K ≥4) showed poor QoL compared with those with lower disease activity (SLEDAI-2K <4), with significant differences in the domains of physical health, planning, burden to others and fatigue (p = 0.001, p = 0.04, p = 0.03, p = 0.04, respectively). The confirmatory factor analysis using the eight domain loadings of the 34 items showed a poor fit (χ(2)/degree of freedom (df) 2.26, χ(2 )= 1128.6 (p < 0.001), root mean square error of approximation (RMSEA) = 0.167; goodness-of-fit index (GFI) = 0.606, comparative fit index (CFI) = 0.649)). Screeplot analysis suggested a five-factor loading structure and confirmatory factor analysis result of which is similar to the eight-factor model. A good internal consistency was observed (Cronbach's α 0.89-0.91). Test-retest reliability was good to excellent between baseline and day 15 (intraclass correlation coefficient (ICC) 0.90-0.98).
CONCLUSION: The Italian version of the LupusQoL(©) is a valid tool for adult patients with SLE.
© The Author(s) 2014 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.

Entities:  

Keywords:  Autoimmunity; LupusQoL; SF-36; autoantibodies; lupus; quality of life; systemic lupus erythematosus

Mesh:

Year:  2014        PMID: 24569393     DOI: 10.1177/0961203314524466

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  13 in total

1.  Components of quality of life in a sample of patients with lupus: a confirmatory factor analysis and Rasch modeling of the LupusQoL.

Authors:  Ana-Belén Meseguer-Henarejos; Juan-José Gascón-Cánovas; José-Antonio López-Pina
Journal:  Clin Rheumatol       Date:  2017-05-02       Impact factor: 2.980

2.  Validation and reliability of a disease-specific quality-of-life measure in patients with cutaneous lupus erythematosus.

Authors:  M E Ogunsanya; S K Cho; A Hudson; B F Chong
Journal:  Br J Dermatol       Date:  2019-04-07       Impact factor: 9.302

Review 3.  Patient-Reported Outcomes in Systemic Lupus Erythematosus.

Authors:  Mary Mahieu; Susan Yount; Rosalind Ramsey-Goldman
Journal:  Rheum Dis Clin North Am       Date:  2016-03-17       Impact factor: 2.670

4.  Quality of life among female patients with systemic lupus erythematosus in remission.

Authors:  Rudra Prosad Goswami; Rudrani Chatterjee; Parasar Ghosh; Geetabali Sircar; Alakendu Ghosh
Journal:  Rheumatol Int       Date:  2019-05-25       Impact factor: 3.580

5.  Linguistic Validation of the LupusQoL for the Assessment of Quality of Life in Iranian Patients with Systemic Lupus Erythematosus.

Authors:  Naeimehossadat Hosseini; Zahra Sayed Bonakdar; Ali Gholamrezaei; Leila Mirbagher
Journal:  Int J Rheumatol       Date:  2014-09-09

6.  Relationship Between Clinical and Immunological Features with Magnetic Resonance Imaging Abnormalities in Female Patients with Neuropsychiatric Systemic Lupus Erythematosus.

Authors:  Hai-Peng Wang; Cui-Yan Wang; Zheng-Lun Pan; Jun-Yu Zhao; Bin Zhao
Journal:  Chin Med J (Engl)       Date:  2016-03-05       Impact factor: 2.628

7.  Validation of the Malayalam Version of Leeds Assessment of Neuropathic Symptoms and Signs Pain Scale in Cancer Patients in the Regional Cancer Centre, Thiruvananthapuram, Kerala, India.

Authors:  Shoukkathali Anzar; Cherian Koshy; Kurian Mathew Abraham
Journal:  Indian J Palliat Care       Date:  2017 Jul-Sep

8.  Comparison of performance of specific (SLEQOL) and generic (SF36) health-related quality of life questionnaires and their associations with disease status of systemic lupus erythematosus: a longitudinal study.

Authors:  Worawit Louthrenoo; Nuntana Kasitanon; Eric Morand; Rangi Kandane-Rathnayake
Journal:  Arthritis Res Ther       Date:  2020-01-10       Impact factor: 5.156

9.  Health and quality of life outcomes.

Authors:  Meenakshi Jolly; Winston Sequeira; Joel A Block
Journal:  Health Qual Life Outcomes       Date:  2014-12-12       Impact factor: 3.186

10.  Patient-reported outcome measures for use in clinical trials of SLE: a review.

Authors:  Zara Izadi; Julie Gandrup; Patricia P Katz; Jinoos Yazdany
Journal:  Lupus Sci Med       Date:  2018-08-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.